Display Settings:

Format

Send to:

Choose Destination

    Nuklearmedizin. 1985 Apr;24(2):90-2.

    Change of pharmacokinetic parameters of 131I-hippuran caused by heparin.

    Jovanović V, Maksin T, Bzenić J, Terzić N.

    The radiochemical purity of 131I-hippuran determined by radiochromatographic analysis using Whatman No 3 MM paper and a mixture of n-butanol, acetic acid and water as developer, was 97.3 +/- 1.2%. O-131IB acid and less than 1% of free 131I were separated from the preparation. No radioactivity which would correspond to O-131IB acid was observed on the radiochromatogram when 131I-hippuran was incubated with HSA and heparin. Protein binding of 131I-hippuran as a function of radiochemical purity, and HSA and heparin concentrations were determined by the method of equilibrium dialysis. No effect of radiochemical purity on protein binding of 131I-hippuran was observed, the value obtained being 1.3 +/- 0.1%. Higher HSA concentrations increased protein binding but decreased retention activity on the dialysing membrane. Heparin decreased protein binding of 131I-hippuran by 47%. The biological half-times of excretion of 131I-hippuran with heparin were 4 min for the fast phase and 107 min for the slow phase. The results of biodistribution in experimental animals showed increased localization of 131I-hippuran with heparin in the kidneys and liver during the first 15 min after injection.

    PMID: 4022787 [PubMed - indexed for MEDLINE]

    Supplemental Content

    Click here to read

    Patient drug information

    • Heparin Injection

      Heparin is used to prevent blood clots from forming in people who have certain medical conditions or who are undergoing certain medical procedures that increase the chance that clots will form. Heparin is also used to st...